PUBLISHED-SEQUENCE ANTIBODY · SC-PSA-0941

Pagibaximab antibody

Staphylococcal lipoteichoic acid/LTA

Available by inquiry

Pagibaximab is a research antibody reference targeting Staphylococcal lipoteichoic acid/LTA. Pure and fluorescently conjugated formats are available by inquiry.

Catalog number
SC-PSA-0941
Target
Staphylococcal lipoteichoic acid/LTA
Available formats
Pure or fluorescently conjugated
Research use
For research use only

Product information

Available labeling options

Pure · Biotin · BV421 · V450 · V500 · AF488 · PerCP-Cy5.5 · PE · AF594 · PE-Cy5 · PE-Cy7 · APC · AF700 · APC-Cy7

Tell us the intended application, amount and preferred label. Final configuration and delivery are confirmed in the quotation.

PUBLIC REFERENCE

Reference source

US20100221822A1 / US7884198B2, MAB 96-110 VH/VL SEQ ID NOs. 87 and 89 with human constant regions

View reference ↗
START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact us
Pagibaximab Antibody (Staphylococcal lipoteichoic acid/LTA) | StellaCyte